Related Experiment Video
Updated: Aug 23, 2026

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
Published on: May 17, 2024
Diabetes in pregnancy and infant adiposity: systematic review and meta-analysis
Karen M Logan1, Chris Gale1, Matthew J Hyde1
1Section of Neonatal Medicine, Chelsea and Westminster Hospital Campus, Imperial College London, London, UK.
Insights
Infants of mothers with diabetes (IDM) have significantly higher fat mass compared to infants of mothers without diabetes (NIDM). This increased adiposity in IDM, particularly in boys, warrants further investigation into interventions for improved later health outcomes.
Area of Science:
- Perinatology
- Pediatric Endocrinology
- Metabolic Health
Background:
- Maternal diabetes is linked to increased newborn adiposity.
- Infants of diabetic mothers (IDM) face higher risks of adverse metabolic health.
- Adiposity may mediate the metabolic risks in IDM.
Purpose of the Study:
- To systematically review and meta-analyze adiposity differences between IDM and infants of mothers without diabetes (NIDM).
- To compare fat mass, fat-free mass, body fat percentage, and skinfold thickness.
- To analyze subgroups based on maternal diabetes type and infant sex.
Main Methods:
- Systematic review and random-effects meta-analysis of observational studies.
- Inclusion of data from 35 papers and over 24,000 infants.
- Subgroup analyses by maternal diabetes type (type 1, type 2, gestational) and infant sex.
- Examination of pre-pregnancy body mass index (BMI) influence.
Main Results:
- IDM exhibited significantly greater fat mass than NIDM (83g difference).
- Higher fat mass was observed in infants of mothers with gestational diabetes (62g) and type 1 diabetes (268g).
- Increased fat mass was significant in IDM boys (87g) but not in IDM girls.
- Results were consistent after adjusting for maternal BMI.
Conclusions:
- Infants of diabetic mothers demonstrate significantly higher adiposity compared to NIDM.
- These findings support research into interventions aimed at reducing infant adiposity.
- Reducing infant adiposity may improve long-term metabolic health outcomes.
Objective:
Maternal glycaemia and anthropometry-derived newborn adiposity are strongly correlated. The children of mothers with diabetes are at greater risk of adverse metabolic health, and increased adiposity is a plausible mediator. We undertook a systematic review and meta-analysis to compare adiposity in infants of diabetic mothers (IDM) and infants of mothers without diabetes (NIDM).
Design:
We identified observational studies reporting adiposity in IDM and NIDM. We searched references, traced forward citations and contacted authors for additional data. We considered all body composition techniques and compared fat mass, fat-free mass, body fat % and skinfold thickness. We used random effects meta-analyses and performed subgroup analyses by maternal diabetes type (type 1, type 2 and gestational) and infant sex. We examined the influence of pre-pregnancy body mass index (BMI) and conducted sensitivity analyses.
Results:
We included data from 35 papers and over 24 000 infants. IDM have greater fat mass than NIDM (mean difference (95% CI)): 83 g (49 to 117). Fat mass is greater in infants of mothers with gestational diabetes: 62 g (29 to 94) and type 1 diabetes: 268 g (139 to 397). Insufficient studies reported data for type 2 diabetes separately. Compared with NIDM, fat mass was greater in IDM boys: 87 g (30 to 145), but not significantly different in IDM girls: 42 g (-33 to 116). There was no attenuation after adjustment for maternal BMI.
Conclusions:
IDM have significantly greater adiposity in comparison with NIDM. These findings are justification for studies to determine whether measures to reduce infant adiposity will improve later health.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Introduction
Type II Diabetes I: Introduction

